The Joint Pain, Frozen Shoulder, and Plantar Fasciitis Nobody Told You Were Hormonal

The Joint Pain, Frozen Shoulder, and Plantar Fasciitis Nobody Told You Were Hormonal

Musculoskeletal syndrome of menopause — misdiagnosed, misunderstood, and very treatable

I want to tell you something I don’t share lightly: for years, I attributed my own joint pain, hip pain, and foot pain to Lyme disease.

I’m a nurse practitioner. I work in hormone health. And I still missed it in myself — not because I wasn’t paying attention, but because the connection between estrogen and musculoskeletal tissue simply wasn’t part of my training, or most of the clinical literature I was reading at the time. The joints and tendons and fascia of the body are not where anyone was looking when they thought about menopause.

It wasn’t until I took a serious look at my own hormones and dove into the emerging research on what is now formally recognized as the musculoskeletal syndrome of menopause that something clicked. The timeline of my symptoms matched my hormonal transition almost perfectly. The gluteal tendinopathy and hip pain that came on gradually in my early 40s. The plantar fasciitis that made the first steps of every morning feel like walking on broken glass. The joint achiness and what appeared to be early arthritis that moved around and never quite pointed to a single cause.

I am not telling this story because every woman’s joint pain in midlife is hormonal. I’m telling it because the connection is real, it is frequently missed, and you deserve to know it exists — so you can ask better questions than I knew to ask for myself.

What is musculoskeletal syndrome of menopause?

Musculoskeletal syndrome of menopause is a term that has gained recognition in the clinical literature only in recent years, though the symptoms it describes have been reported by perimenopausal and menopausal women for generations. It refers to a constellation of joint, tendon, muscle, and connective tissue changes that are driven or significantly worsened by declining estrogen.

The syndrome includes:

• Joint pain and stiffness — particularly in the hands, knees, hips, and spine — that is not explained by injury, osteoarthritis imaging, or inflammatory markers

• Frozen shoulder (adhesive capsulitis) — a painful, progressive restriction of shoulder mobility that disproportionately affects women in their 40s and 50s

• Plantar fasciitis — inflammation of the connective tissue on the sole of the foot, causing sharp heel pain especially with the first steps of the morning

• Tendinopathies — tendon pain and dysfunction including rotator cuff issues, tennis elbow, and Achilles tendon problems without clear overuse injury

• Generalized muscle aching — a diffuse, migratory achiness that moves around the body and doesn't localize consistently

• Collagen matrix degradation — loss of connective tissue integrity across joints, skin, and pelvic floor structures as estrogen-dependent collagen production declines

The reason this cluster of symptoms gets missed — or attributed to aging, overuse, autoimmune conditions, fibromyalgia, or in my case Lyme disease — is that none of these individually screams “estrogen.” They each have their own medical workup, their own specialist, their own standard treatment. The hormonal thread connecting them is rarely followed.

Why estrogen matters so much to joints and connective tissue

Estrogen receptors are present throughout the musculoskeletal system — in cartilage, bone, synovial tissue, tendons, ligaments, and fascia. This is not a peripheral fact. It means that estrogen is actively involved in maintaining the health and function of these structures, and that its decline — particularly the erratic, spiking-and-crashing pattern of perimenopause — has direct consequences throughout the body’s structural framework.

Here’s what estrogen does in the musculoskeletal system:

• Regulates collagen production — estrogen stimulates fibroblasts (the cells that produce collagen) and maintains the collagen matrix in joints, tendons, ligaments, and skin. As estrogen declines, collagen synthesis decreases and collagen degradation accelerates. The result is connective tissue that is less elastic, less well-hydrated, and more prone to injury and inflammation.

• Reduces inflammation — estrogen has direct anti-inflammatory effects on synovial tissue (the lining of joints) and tendons. When estrogen fluctuates or drops, inflammatory cytokines increase and joints become more reactive. This is why many women notice joint symptoms worsening in the week before their period — when progesterone and estrogen are at their lowest — and improving in the follicular phase.

• Supports cartilage maintenance — estrogen promotes the synthesis of proteoglycans, the molecules that give cartilage its cushioning properties. Lower estrogen means less cartilage maintenance and faster degradation — contributing to joint space narrowing and pain even in the absence of classical osteoarthritis.

• Regulates tendon structure — estrogen influences the mechanical properties of tendons, including their stiffness and their ability to withstand load. Studies have shown that tendon stiffness changes across the menstrual cycle and with estrogen status, which contributes to the increased rate of tendon injury and tendinopathy in perimenopausal and postmenopausal women.

• Modulates pain sensitivity — estrogen has analgesic properties and influences how the nervous system processes pain signals. Lower estrogen increases central pain sensitization — meaning the same stimulus is experienced as more painful. This is why widespread musculoskeletal pain in perimenopause is often disproportionate to any structural finding on imaging.

A clinical note from personal experience:

Gluteal tendinopathy and hip pain were among my most persistent symptoms — and the ones I was most certain were something other than hormonal. The deep, aching quality that worsened with certain movements and positions, the way it crept up gradually and became part of my daily baseline. Looking back, the timing was exactly right: early perimenopause, estrogen volatility at its height, collagen integrity declining. Tendon tissue is heavily estrogen-dependent. The dramatically increased rate of tendinopathy in perimenopausal and postmenopausal women is not a coincidence.

If you have been managing hip pain, tendinopathy, or deep joint aching and no one has asked about your hormones, that conversation is worth having.

The misdiagnosis problem

The symptoms of musculoskeletal syndrome of menopause overlap significantly with several other conditions — which is why women spend years pursuing the wrong diagnosis, the wrong treatment, and the wrong specialist.

• Rheumatoid arthritis — symmetric joint pain and morning stiffness are shared features. The distinction lies in inflammatory markers (RF, anti-CCP, CRP, ESR), which are typically normal in hormonal joint pain, and in the absence of joint erosion on imaging.

• Fibromyalgia — widespread musculoskeletal pain, fatigue, and sleep disruption overlap almost completely. Many women receive a fibromyalgia diagnosis during perimenopause when the underlying driver is hormonal. The two can coexist, but treating fibromyalgia without addressing hormonal root cause leaves a significant driver unaddressed.

• Lyme disease — as in my own case, the migratory joint pain, fatigue, and cognitive symptoms of perimenopause can closely mimic Lyme disease, particularly in women who live in endemic areas. A positive Lyme titer in a perimenopausal woman should be interpreted carefully, as false positives occur and the timeline of symptoms should be weighed against hormonal history.

• Hypothyroidism — joint pain, muscle aching, and stiffness are prominent hypothyroid symptoms. Given that thyroid and hormone symptoms coexist and interact in perimenopause, both should be evaluated.

• Overuse injury — plantar fasciitis and tendinopathies are frequently attributed to activity level, footwear, or biomechanics when the underlying vulnerability is estrogen-dependent connective tissue loss. Treatment focused on activity modification and physical therapy may help but doesn't address the root hormonal driver.

The moment I connected it:

When I finally reviewed my own hormone history alongside my symptom timeline, the correlation was striking. The joint pain and hip pain began in earnest as my cycles started to shift. The gluteal tendinopathy developed during a period of significant hormonal fluctuation. The plantar fasciitis came and went in patterns that, in retrospect, tracked with my luteal phase — the lowest estrogen and progesterone phase of each cycle.

I had been looking for a pathogen when I should have been looking at my own hormonal transition. That experience is a significant part of why I built this practice.

What the collagen matrix means for your whole body

Collagen is the most abundant protein in the human body. It forms the structural scaffolding of skin, joints, tendons, ligaments, bone matrix, blood vessel walls, and pelvic floor tissue. Estrogen is one of the primary regulators of collagen synthesis and maintenance throughout this entire system.

As estrogen declines in perimenopause, collagen loss accelerates across all of these structures simultaneously. This is why the musculoskeletal syndrome of menopause is not just about joints in isolation — it is part of a broader connective tissue picture that includes:

• Skin thinning and loss of elasticity — as the same collagen-producing mechanisms that support joints decline in the skin

• Pelvic floor laxity — contributing to bladder urgency, stress incontinence, and pelvic organ prolapse

• Vaginal tissue changes — part of the genitourinary syndrome of menopause, driven by the same collagen and estrogen-dependent tissue changes

• Bone density loss — estrogen is a primary regulator of bone remodeling; its decline accelerates bone loss and increases fracture risk

• Gum and dental changes — collagen-dependent periodontal tissue is also estrogen-sensitive, and some women notice increased gum sensitivity or recession during perimenopause

This is not a list of separate problems. It is one problem — systemic collagen and connective tissue decline driven by estrogen loss — expressing itself across multiple organ systems at once. Understanding it as a unified process changes how you think about treatment.

What actually helps

Because the musculoskeletal syndrome of menopause is driven primarily by estrogen’s role in connective tissue maintenance, the most effective interventions work at the root level.

• Hormone support — restoring estrogen, where appropriate and individually evaluated, directly supports collagen synthesis, reduces joint inflammation, maintains cartilage, and normalizes pain sensitivity. Many women report significant reduction in joint symptoms within weeks to months of initiating hormone therapy. This is not coincidence — it is the estrogen-receptor-mediated restoration of connective tissue support.

• Comprehensive hormone evaluation — because the musculoskeletal symptoms of perimenopause are often the presenting complaint rather than the classic hot flash or cycle change, a woman with joint pain, frozen shoulder, or widespread achiness in her 40s deserves a hormonal workup even if she hasn't yet identified herself as perimenopausal.

• Collagen support — dietary protein adequate to support collagen synthesis, vitamin C (required for collagen cross-linking), and targeted collagen peptide supplementation have evidence supporting their role in connective tissue health. These are adjuncts, not substitutes for addressing the hormonal driver.

• Anti-inflammatory support — omega-3 fatty acids, magnesium, and curcumin have evidence for reducing musculoskeletal inflammation and can be useful alongside hormonal treatment.

• Strength training — resistance exercise stimulates collagen synthesis in tendons and ligaments and helps maintain the muscle mass that supports joint stability. For women in perimenopause, it is one of the most impactful lifestyle interventions for musculoskeletal health, bone density, and metabolic function simultaneously.

• Physical therapy for specific conditions — frozen shoulder, plantar fasciitis, and tendinopathies respond to targeted physical therapy. These interventions are more effective when the underlying hormonal vulnerability is also being addressed.

The bottom line

If you have been managing joint pain, shoulder restriction, heel pain, or widespread body aching in your 40s or 50s — and no one has asked about your hormones — you may have been treating the expression of a problem rather than its cause.

The musculoskeletal syndrome of menopause is not fringe science. It is recognized in the clinical literature, it has a clear biological mechanism, and it responds to treatment when the hormonal driver is identified and addressed.

I spent years looking for an answer in the wrong place. I’m writing this so you don’t have to.

Ready to look at the full picture?

Book a Discovery Call or Initial Consult with Leslie, APRN

Virtual Visit $250 for 60 minutes

www.optimizeandelevate.com

This article is for educational purposes only and does not constitute medical advice. Joint pain, musculoskeletal symptoms, and connective tissue changes have multiple potential causes. If you are experiencing these symptoms, please consult a qualified healthcare provider for evaluation. The personal experiences described reflect the author’s individual history and are shared for illustrative purposes only.